Virus Vaccine Timeline for Delivery Start at the end of November 2020

Translate to Spanish or other 102 languages!

Image for illustration purposes only. By The National Guard under CC BY 2.0

Mega Doctor News

- Advertisement -
William Eugene “Gene” Powell
Photo by UTSA

According to Eugene Powell, the Texas Vice Chairman for the Republican National Committee, the timeline for the delivery of the vaccine has changed in a positive way since Pfizer’s announcement that they are ready.  “To their credit the Trump team has, for several months, been getting ready for this day.”

He also pointed out that the US Military has been preparing the logistics for getting the vaccine out to everyone in an orderly and efficient manner.  Currently the timeline looks like this:

  1. End of November to Mid-December: Elderly, Nursing Home patients and staff Vaccinated.
  2. Mid December to Early January:  Health Care Workers Vaccinated
  3. Mid-January through Mid-April:  All other citizens Vaccinated

During this four-month period additional vaccines will be approved and will be added to the mix. 

- Advertisement -

Bottom line is that if you want to be vaccinated you will have an opportunity to do so sometime over the next four months.

“The doctors I have talked tell me emphatically that this is a real game changer and all thanks to the Trump Team and Operation Warp Speed.” Mr. Powell continued, “Otherwise, we could have been waiting four or five years for a vaccine.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -